Kimberly Kelly, Ph.D.
Founder and Professor of Biomedical Engineering
Professional Overview
Kimberly Kelly, Ph.D., is a renowned biomedical engineer and the Founder of ZielBio, Inc., a cutting-edge biotechnology company. With over 15 years of industry experience, she is a respected expert in the development of innovative medical technologies and treatments.
Experience Summary
Current Role
As the Founder of ZielBio, Inc., Dr. Kelly is responsible for leading the company's strategic vision, driving research and development, and managing cross-functional teams to bring transformative biomedical solutions to market. Under her guidance, ZielBio has emerged as a leader in the development of targeted cancer therapies, leveraging her expertise in cell biology, protein engineering, and translational research.
In addition to her role at ZielBio, Dr. Kelly serves as a Professor of Biomedical Engineering at the University of Virginia, where she conducts cutting-edge research, mentors students, and collaborates with leading researchers in the field.
Career Progression
Prior to founding ZielBio, Dr. Kelly held senior leadership positions, including Chief Executive Officer and President at the company. Before that, she served as an Assistant Professor at Massachusetts General Hospital, where she made significant contributions to the development of novel medical devices and therapeutic approaches.
Throughout her career, Dr. Kelly has demonstrated a strong track record of driving innovation, fostering collaborative partnerships, and translating research into real-world impact. Her achievements have been recognized through numerous awards and accolades, including the prestigious National Institutes of Health (NIH) Director's New Innovator Award and the American Institute for Medical and Biological Engineering (AIMBE) Fellow designation.
Academic Background
Dr. Kimberly Kelly holds a Ph.D. in Biomedical Engineering from the Massachusetts Institute of Technology (MIT), where she specialized in tissue engineering and regenerative medicine. Her doctoral research laid the groundwork for several groundbreaking advancements in the field.
Areas of Expertise
- Biomedical engineering and medical technology development
- Cancer biology and targeted therapy design
- Protein engineering and molecular biology
- Translational research and clinical translation
- Entrepreneurship and startup leadership
- Academic research and teaching in the field of biomedical engineering
Professional Impact
Under Dr. Kelly's leadership, ZielBio has secured multiple patents and has been recognized for its innovative approach to cancer treatment. The company's lead product candidate has demonstrated promising results in early-stage clinical trials, offering hope to patients with hard-to-treat cancer types.
In her academic role, Dr. Kelly has published extensively in peer-reviewed journals, supervised numerous graduate students, and served on the editorial boards of leading biomedical engineering journals. Her research has been instrumental in advancing the understanding of cellular mechanisms and their potential applications in the development of novel therapies.
Conclusion
With her exceptional track record of innovation, entrepreneurship, and academic excellence, Dr. Kimberly Kelly is poised to continue making significant contributions to the field of biomedical engineering. Her commitment to translating research into real-world solutions and her ability to drive collaborative partnerships position her as a visionary leader in the rapidly evolving biotechnology industry.
